Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 1191 - 1200 of 2525

  • Cholesterol-lowering statins prescribed less later in day

    Furthering efforts to understand why potentially life-saving statins are so under-prescribed among American patients with heart disease, a new study shows that clinicians are more likely to sign a script for them earlier in the day. Researchers in Penn Medicine’s Nudge Unit found that patients with the very first appointments of the day were most likely to have statins prescribed, and the odds progressively fell through the morning and remained low throughout the afternoon. 

    FULL STORY AT Penn Medicine News →

  • Pathway behind muscle breakdowns in Duchenne muscular dystrophy discovered

    An overactive genetic pathway in muscle stem cells was found to shorten the ends of chromosomes, called telomeres, resulting in DNA damage that impedes the normal healing response, according to a new study by researchers in Penn’s Perelman School of Medicine. The researchers believe this finding unveils the body’s origin point for the chronic muscle injuries associated with diseases like Duchenne muscular dystrophy. 

    FULL STORY AT Penn Medicine News →

  • Harun Küçük named new director of Middle East Center

    Associate Professor in the Department of History and Sociology of Science Harun Küçük, a historian of early modern Ottoman science, will be assuming the leadership of the Center on July 1, 2021.

    FULL STORY AT Penn Arts & Sciences →

  • Meet the 2021-22 Perry World House student fellows

    Perry World House has selected 33 undergraduate students for its 2021-22 World House Student Fellows program. The student fellows represent all four of Penn’s undergraduate schools, sharing a keen interest in global affairs.

    FULL STORY AT Perry World House →

  • New mechanism of lung tissue regeneration refutes widely held assumptions on how alveolar epithelial cells differentiate

    New research study findings from Penn Medicine, published in Cell Stem Cell, show that the long-held assumption that alveolar type 1 and alveolar type 2 cells behave the same way in children and in adults is untrue. The findings could impact the understanding of regenerative lung therapies and why COVID-19 and other viruses affect children differently than adults.

    FULL STORY AT Penn Medicine News →

  • PARP inhibitor shrinks tumors in pancreatic cancer patients with mutations

    More than two-thirds of pancreatic cancer patients harboring genetic mutations saw their tumor stop growing or shrink substantially after being switched from intensive chemotherapy to the PARP inhibitor rucaparib as a maintenance therapy, researchers from the Abramson Cancer Center reported online in the Journal of Clinical Oncology.

    FULL STORY AT Penn Medicine News →

  • How opioid supply shortages shape emergency department prescribing behaviors

    A Penn Medicine study reveals that external factors, such as the volume of pre-filled syringes, or a default number of opioid tablets that could easily be ordered at discharge, can shift prescribing and compel emergency department physicians to administer or prescribe greater quantities of opioids. Opioid prescribing behavior can also be decreased by external factors, such as a supply shortage.

    FULL STORY AT Penn Medicine News →

  • University of Pennsylvania Carey Law School establishes the Cozen Family Voting Rights Fellowship

    With the support of a multiyear gift from Steve and Sandy Cozen, the University of Pennsylvania Carey Law School has launched the Cozen Family Voting Rights Fellowship, which will provide two years of funding for a graduate working to advance and protect voting rights.

    FULL STORY AT Penn Carey Law →

  • New method identifies tau aggregates occurring in healthy body structures

    Penn Medicine researchers used microscopy and machine learning to distinguish tau protein aggregates occurring as part of healthy functions from those occurring in disease.

    FULL STORY AT Penn Medicine News →

  • $3.5 million grant supports effort led by Penn Medicine to diversify Alzheimer’s disease research

    The Pennsylvania Department of Health’s Commonwealth Universal Research Enhancement program will award a $3.5 million grant to Penn Medicine researchers and community partners to address the underrepresentation of Black adults in Alzheimer’s disease research.

    FULL STORY AT Penn Medicine News →